Anisofolin ACAS# 83529-71-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 83529-71-9 | SDF | Download SDF |
PubChem ID | 21721971 | Appearance | Yellow powder |
Formula | C39H32O14 | M.Wt | 724.7 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(2R,3R,4S,5R,6S)-3,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate | ||
SMILES | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)O)OC(=O)C=CC6=CC=C(C=C6)O)O)O | ||
Standard InChIKey | LHMKSPOTCLVAKR-AVMIHGAISA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Anisofolin A has promising antimalarial activity (IC50 4.39 ± 0.25 uM). 2. Anisofolin A has promising antimycobacterium activity [IC50 4.50 ± 0.75 uM (3.31 ug/mL)] against M. tuberculosis H37Ra and at 100 ug/mL, shows 55.6 % inhibition of M. bovis. |
Targets | Antifection |
Anisofolin A Dilution Calculator
Anisofolin A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.3799 mL | 6.8994 mL | 13.7988 mL | 27.5976 mL | 34.497 mL |
5 mM | 0.276 mL | 1.3799 mL | 2.7598 mL | 5.5195 mL | 6.8994 mL |
10 mM | 0.138 mL | 0.6899 mL | 1.3799 mL | 2.7598 mL | 3.4497 mL |
50 mM | 0.0276 mL | 0.138 mL | 0.276 mL | 0.552 mL | 0.6899 mL |
100 mM | 0.0138 mL | 0.069 mL | 0.138 mL | 0.276 mL | 0.345 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Leucosceptoside A
Catalog No.:BCN7457
CAS No.:83529-62-8
- 4-[4-(3-Hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-d]pyrazol-5-yl]benzoic acid
Catalog No.:BCC6341
CAS No.:834903-43-4
- Grantaline
Catalog No.:BCN2083
CAS No.:83482-61-5
- Ginsenoside Rd2
Catalog No.:BCN8279
CAS No.:83480-64-2
- Voglibose
Catalog No.:BCC4750
CAS No.:83480-29-9
- Mifamurtide
Catalog No.:BCC5241
CAS No.:83461-56-7
- Ginsenoside Ra1
Catalog No.:BCN8392
CAS No.:83459-41-0
- Ebracteolata cpd B
Catalog No.:BCN3781
CAS No.:83459-37-4
- Boc-D-Prolinol
Catalog No.:BCC2707
CAS No.:83435-58-9
- ICI 154,129
Catalog No.:BCC5677
CAS No.:83420-94-4
- Phenformin HCl
Catalog No.:BCC4362
CAS No.:834-28-6
- PL 017
Catalog No.:BCC5864
CAS No.:83397-56-2
- 2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane
Catalog No.:BCC8490
CAS No.:83558-87-6
- Regorafenib hydrochloride
Catalog No.:BCC1883
CAS No.:835621-07-3
- Cropodine
Catalog No.:BCN2073
CAS No.:83601-85-8
- Cyclosporin H
Catalog No.:BCC6448
CAS No.:83602-39-5
- (S)-AMPA
Catalog No.:BCC6583
CAS No.:83643-88-3
- CGRP (rat)
Catalog No.:BCC5712
CAS No.:83651-90-5
- RHC 80267
Catalog No.:BCC8083
CAS No.:83654-05-1
- (R)-AMPA
Catalog No.:BCC6582
CAS No.:83654-13-1
- Dihydrosesamin
Catalog No.:BCN6616
CAS No.:83708-70-7
- Ilexside I
Catalog No.:BCN3244
CAS No.:83725-19-3
- Pomolic acid 28-O-beta-D-glucopyranosyl ester
Catalog No.:BCN1334
CAS No.:83725-24-0
- 3alpha-Acetoxy-20(29)-lupene-23,28-dioic acid
Catalog No.:BCN7508
CAS No.:83725-41-1
Studies on Nepalese crude drugs. XXIX. Chemical constituents of Dronapuspi, the whole herb of Leucas cephalotes SPRENG.[Pubmed:17015972]
Chem Pharm Bull (Tokyo). 2006 Oct;54(10):1370-9.
From the whole herb of Leucas cephalotes SPRENG., new labdane-, norlabdane- and abietane-type diterpenes named leucasdins A (1), B (2) and C (3), respectively, and two protostane-type triterpenes named leucastrins A (4) and B (5) were isolated, together with a known triterpene, oleanolic acid, five sterols, 7-oxositosterol, 7-oxostigmasterol, 7alpha-hydroxysitosterol, 7alpha-hydroxystigmasterol and stigmasterol, and eight flavones, 5-hydroxy-7,4'-dimethoxyflavone, pillion, gonzalitosin I, tricin, cosmosin, apigenin 7-O-beta-D-(6-O-p-coumaroyl)glucopyranoside, Anisofolin A and luteolin 4'-O-beta-D-glucuronopyranoside. The structures of 1--5 were determined as (3S,6R,8R,9R,13S,16S)-9,13,15,16-bisepoxy-3,16-diacetoxy-6-formyloxylabdane, (3S,6R)-3-acetoxy-6-formyloxy-iso-ambreinolide, (4R,9S,12R,13R)-12,13-dihydroxyabiet-7-en-18-oic acid, (3S,17S,20S,24S)-3,20-dihydroxy-24-methylprotost-25-en, and (3S,17S,20S,24S)-3,20,24-trihydroxyprotost-25-en respectively, based on spectral and chemical data.